{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:31:18Z","timestamp":1793363478460,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-034"],"award-info":[{"award-number":["2022-PUMCH-B-034"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["No.2021-I2M-1-058"],"award-info":[{"award-number":["No.2021-I2M-1-058"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32271470"],"award-info":[{"award-number":["32271470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02466-9","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:45:32Z","timestamp":1760456732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Exploring personalized prediction of clinical chemotherapy efficacy and revealing tumor heterogeneity using patient-derived 3D bioprinting gastric cancer models"],"prefix":"10.1186","volume":"24","author":[{"given":"Liwei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuce","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangze","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunda","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penglei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"2466_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2466_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathologica Microbiol Scand. 1965;64:31\u201349.","journal-title":"Acta Pathologica Microbiol Scand"},{"key":"2466_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"CGAR Network","year":"2014","unstructured":"Network CGAR. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202.","journal-title":"Nature"},{"key":"2466_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/ajco.12089","volume":"9","author":"M Ter-Ovanesov","year":"2013","unstructured":"Ter-Ovanesov M, Yalcin S, Zalcberg J, Hitier S, Bang YJ, Wu CW, et al. Registry of gastric cancer treatment evaluation (REGATE): part II treatment practice. Asia Pac J Clin Oncol. 2013;9:373\u201380.","journal-title":"Asia Pac J Clin Oncol"},{"key":"2466_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"2466_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","volume":"16","author":"JJF Sleeboom","year":"2024","unstructured":"Sleeboom JJF, van Tienderen GS, Schenke-Layland K, van der Laan LJW, Khalil AA, Verstegen MMA. The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets. Sci Transl Med. 2024;16:eadg3840.","journal-title":"Sci Transl Med"},{"key":"2466_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41569-024-01103-0","volume":"22","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhou J, Kong W. Extracellular matrix in vascular homeostasis and disease. Nat Rev Cardiol. 2025;22:333\u201353.","journal-title":"Nat Rev Cardiol"},{"key":"2466_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ejca.2003.11.028","volume":"40","author":"L Kelland","year":"2004","unstructured":"Kelland L. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer. 2004;40:827\u201336.","journal-title":"Eur J Cancer"},{"key":"2466_CR9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.21037\/hbsn.2017.06.03","volume":"6","author":"M Moro","year":"2017","unstructured":"Moro M, Casanova M, Roz L. Patient-derived xenografts, a multi-faceted in vivo model enlightening research on rare liver cancer biology. Hepatobiliary Surg Nutr. 2017;6:344.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2466_CR10","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4:998\u20131013.","journal-title":"Cancer Discov"},{"key":"2466_CR11","doi-asserted-by":"crossref","unstructured":"Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F. Human lung adenocarcinoma-derived organoid models for drug screening. IScience 2020, 23.","DOI":"10.1016\/j.isci.2020.101411"},{"key":"2466_CR12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson D, Clevers H. Cancer modeling meets human organoid technology. Science. 2019;364:952\u20135.","journal-title":"Science"},{"key":"2466_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","volume":"24","author":"F Weeber","year":"2017","unstructured":"Weeber F, Ooft SN, Dijkstra KK, Voest EE. Tumor organoids as a pre-clinical cancer model for drug discovery. Cell Chem Biology. 2017;24:1092\u2013100.","journal-title":"Cell Chem Biology"},{"key":"2466_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jcmgh.2018.09.008","volume":"7","author":"NG Steele","year":"2019","unstructured":"Steele NG, Chakrabarti J, Wang J, Biesiada J, Holokai L, Chang J, et al. An organoid-based preclinical model of human gastric cancer. Cell Mol Gastroenterol Hepatol. 2019;7:161\u201384.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2466_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-023-01919-3","volume":"23","author":"T Schm\u00e4che","year":"2024","unstructured":"Schm\u00e4che T, Fohgrub J, Klimova A, Laaber K, Drukewitz S, Merboth F, Hennig A, Seidlitz T, Herbst F, Baenke F. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold. Mol Cancer. 2024;23:10.","journal-title":"Mol Cancer"},{"key":"2466_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101627","volume":"5","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Li S, Zhu L, Huang M, Xie Y, Song X, et al. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer. Cell Rep Med. 2024;5:101627.","journal-title":"Cell Rep Med"},{"issue":"12","key":"2466_CR17","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/cac2.12224","volume":"41","author":"J Qu","year":"2021","unstructured":"Qu J, Kalyani FS, Liu L, Cheng T, Chen L. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy. Cancer Commun. 2021;41(12):1331\u201353.","journal-title":"Cancer Commun"},{"key":"2466_CR18","doi-asserted-by":"publisher","first-page":"120416","DOI":"10.1016\/j.biomaterials.2020.120416","volume":"265","author":"F Xie","year":"2021","unstructured":"Xie F, Sun L, Pang Y, Xu G, Jin B, Xu H, Lu X, Xu Y, Du S, Wang Y. Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine. Biomaterials. 2021;265:120416.","journal-title":"Biomaterials"},{"key":"2466_CR19","doi-asserted-by":"publisher","first-page":"035020","DOI":"10.1088\/1758-5090\/acd960","volume":"15","author":"K Xu","year":"2023","unstructured":"Xu K, Huang Y, Wu M, Yin J, Wei P. 3D bioprinting of multi-cellular tumor microenvironment for prostate cancer metastasis. Biofabrication. 2023;15:035020.","journal-title":"Biofabrication"},{"key":"2466_CR20","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Hu Q, Pei Y, Luo H, Wang Z, Xu X, Zhang Q, Dai J, Wang Q, Fan Z, et al. A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments. Nat Commun. 2024;15:3382.","journal-title":"Nat Commun"},{"key":"2466_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41422-020-0338-1","volume":"30","author":"M Tang","year":"2020","unstructured":"Tang M, Xie Q, Gimple RC, Zhong Z, Tam T, Tian J, Kidwell RL, Wu Q, Prager BC, Qiu Z. Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions. Cell Res. 2020;30:833\u201353.","journal-title":"Cell Res"},{"issue":"4","key":"2466_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.biotechadv.2015.12.011","volume":"34","author":"C Mandrycky","year":"2016","unstructured":"Mandrycky C, Wang Z, Kim K, Kim D-H. 3D bioprinting for engineering complex tissues. Biotechnol Adv. 2016;34(4):422\u201334.","journal-title":"Biotechnol Adv"},{"key":"2466_CR23","doi-asserted-by":"publisher","DOI":"10.1063\/1.5050245","volume":"5","author":"C Yu","year":"2018","unstructured":"Yu C, Zhu W, Sun B, Mei D, Gou M, Chen S. Modulating physical, chemical, and biological properties in 3D printing for tissue engineering applications. Appl Phys Rev. 2018;5:041107.","journal-title":"Appl Phys Rev"},{"key":"2466_CR24","doi-asserted-by":"publisher","first-page":"2306676","DOI":"10.1002\/adfm.202306676","volume":"34","author":"J Kim","year":"2024","unstructured":"Kim J, Kim J, Gao G, Choi Ym, Kim J, Cho DW, Cheong JH, Jang J. Bioprinted organoids platform with tumor vasculature for implementing precision personalized medicine targeted towards gastric cancer. Adv Funct Mater. 2024;34:2306676.","journal-title":"Adv Funct Mater"},{"key":"2466_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202409321","author":"M Ju","year":"2025","unstructured":"Ju M, Jin Z, Yu X, Huang C, Li Y, Gao Z, et al. Gastric cancer models developed via GelMA 3D bioprinting accurately mimic cancer hallmarks, tumor microenvironment features, and drug responses. Small. 2025. https:\/\/doi.org\/10.1002\/smll.202409321.","journal-title":"Small"},{"key":"2466_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411769","author":"Ym Choi","year":"2025","unstructured":"Choi Ym, Na D, Yoon G, Kim J, Min S, Yi HG, et al. Prediction of patient drug response via 3D bioprinted gastric cancer model utilized patient-derived tissue laden tissue\u2010specific bioink. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202411769.","journal-title":"Adv Sci"},{"key":"2466_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gutjnl-2019-319960","volume":"70","author":"H Yang","year":"2021","unstructured":"Yang H, Sun L, Pang Y, Hu D, Xu H, Mao S, Peng W, Wang Y, Xu Y, Zheng Y-C. Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure. Gut. 2021;70:567\u201374.","journal-title":"Gut"},{"key":"2466_CR28","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/aba0c3","volume":"12","author":"S Mao","year":"2020","unstructured":"Mao S, He J, Zhao Y, Liu T, Xie F, Yang H, et al. Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing. Biofabrication. 2020;12:045014.","journal-title":"Biofabrication"},{"key":"2466_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304460","volume":"11","author":"H Sun","year":"2024","unstructured":"Sun H, Sun L, Ke X, Liu L, Li C, Jin B, et al. Prediction of clinical precision chemotherapy by patient-derived 3D bioprinting models of colorectal cancer and its liver metastases. Adv Sci. 2024;11:2304460.","journal-title":"Adv Sci"},{"key":"2466_CR30","doi-asserted-by":"crossref","unstructured":"Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, Chan D, Chan AS, Ma S, Lam KO et al. A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. Cell Stem Cell 2018, 23:882\u2013897 e811.","DOI":"10.1016\/j.stem.2018.09.016"},{"key":"2466_CR31","doi-asserted-by":"publisher","first-page":"2200027","DOI":"10.1002\/adhm.202200027","volume":"11","author":"L Ouyang","year":"2022","unstructured":"Ouyang L, Wojciechowski JP, Tang J, Guo Y, Stevens MM. Tunable microgel-templated porogel (MTP) Bioink for 3D Bioprinting applications. Adv Healthc Mater. 2022;11:2200027.","journal-title":"Adv Healthc Mater"},{"key":"2466_CR32","doi-asserted-by":"crossref","unstructured":"Sun H, Wang Y, Sun M, Ke X, Li C, Jin B, Pang M, Wang Y, Jiang S, Du L, et al. Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer. J Adv Res. 2025;74:165-74.","DOI":"10.1016\/j.jare.2024.09.011"},{"key":"2466_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","volume":"388","author":"Y Usui","year":"2023","unstructured":"Usui Y, Taniyama Y, Endo M, Koyanagi YN, Kasugai Y, Oze I, et al. Helicobacter pylori, homologous-recombination genes, and gastric cancer. N Engl J Med. 2023;388:1181\u201390.","journal-title":"N Engl J Med"},{"key":"2466_CR34","doi-asserted-by":"crossref","unstructured":"Zeng Y, Jin RU. Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer. Semin cancer biol. Elsevier; 2022. pp. 566\u201382.","DOI":"10.1016\/j.semcancer.2021.12.004"},{"key":"2466_CR35","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1158\/1078-0432.CCR-18-2275","volume":"25","author":"F Meric-Bernstam","year":"2019","unstructured":"Meric-Bernstam F, Johnson AM, Dumbrava EEI, Raghav K, Balaji K, Bhatt M, et al. Advances in HER2-targeted therapy: novel agents and opportunities beyond breast and gastric cancer. Clin Cancer Res. 2019;25:2033\u201341.","journal-title":"Clin Cancer Res"},{"key":"2466_CR36","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1158\/1078-0432.CCR-23-3523","volume":"30","author":"D Skubleny","year":"2024","unstructured":"Skubleny D, Purich K, McLean DR, Martins-Filho SN, Buttenschoen K, Haase E, et al. The tumor immune microenvironment drives survival outcomes and therapeutic response in an integrated molecular analysis of gastric adenocarcinoma. Clin Cancer Res. 2024;30:5385\u201398.","journal-title":"Clin Cancer Res"},{"key":"2466_CR37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"2466_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","volume":"13","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13:4.","journal-title":"J Hematol Oncol"},{"key":"2466_CR39","first-page":"205","volume":"53","author":"C Zheng","year":"2025","unstructured":"Zheng C, Wang P, Zhang D, Fang Z, Feng Y, Chen J, et al. A novel organoid model retaining the glioma microenvironment for personalized drug screening and therapeutic evaluation. Bioact Mater. 2025;53:205\u201317.","journal-title":"Bioact Mater"},{"key":"2466_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41421-024-00650-7","volume":"10","author":"M Tang","year":"2024","unstructured":"Tang M, Jiang S, Huang X, Ji C, Gu Y, Qi Y, et al. Integration of 3D bioprinting and multi-algorithm machine learning identified glioma susceptibilities and microenvironment characteristics. Cell Discov. 2024;10:39.","journal-title":"Cell Discov"},{"key":"2466_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2024.03.008","volume":"31","author":"S Yin","year":"2024","unstructured":"Yin S, Yu Y, Wu N, Zhuo M, Wang Y, Niu Y, Ni Y, Hu F, Ding C, Liu H. Patient-derived tumor-like cell clusters for personalized chemo-and immunotherapies in non-small cell lung cancer. Cell Stem Cell. 2024;31:717\u201333. e718.","journal-title":"Cell Stem Cell"},{"key":"2466_CR42","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1038\/s41467-021-25122-4","volume":"12","author":"D Na","year":"2021","unstructured":"Na D, Chae J, Cho S-Y, Kang W, Lee A, Min S, Kang J, Kim MJ, Choi J, Lee W. Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts. Nat Commun. 2021;12:4840.","journal-title":"Nat Commun"},{"key":"2466_CR43","doi-asserted-by":"publisher","first-page":"025001","DOI":"10.1088\/1758-5090\/abdb87","volume":"13","author":"S Flores-Torres","year":"2021","unstructured":"Flores-Torres S, Peza-Chavez O, Kuasne H, Munguia-Lopez JG, Kort-Mascort J, Ferri L, Jiang T, Rajadurai CV, Park M, Sangwan V. Alginate\u2013gelatin\u2013Matrigel hydrogels enable the development and multigenerational passaging of patient-derived 3D bioprinted cancer spheroid models. Biofabrication. 2021;13:025001.","journal-title":"Biofabrication"},{"key":"2466_CR44","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Hu Q, Pei Y, Luo H, Wang Z, Xu X, Zhang Q, Dai J, Wang Q, Fan Z. A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments. Nat Commun. 2024;15:3382.","journal-title":"Nat Commun"},{"key":"2466_CR45","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/ng.3967","volume":"49","author":"U Ben-David","year":"2017","unstructured":"Ben-David U, Ha G, Tseng Y-Y, Greenwald NF, Oh C, Shih J, McFarland JM, Wong B, Boehm JS, Beroukhim R. Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet. 2017;49:1567\u201375.","journal-title":"Nat Genet"},{"key":"2466_CR46","doi-asserted-by":"publisher","first-page":"eaaz1723","DOI":"10.1126\/scitranslmed.aaz1723","volume":"12","author":"S Yin","year":"2020","unstructured":"Yin S, Xi R, Wu A, Wang S, Li Y, Wang C, Tang L, Xia Y, Yang D, Li J. Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci Transl Med. 2020;12:eaaz1723.","journal-title":"Sci Transl Med"},{"key":"2466_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104614","author":"L Ou","year":"2023","unstructured":"Ou L, Liu S, Wang H, Guo Y, Guan L, Shen L, et al. Patient-derived melanoma organoid models facilitate the assessment of immunotherapies. EBioMedicine. 2023. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104614.","journal-title":"EBioMedicine"},{"key":"2466_CR48","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1111\/bph.13890","volume":"174","author":"DJ Flanagan","year":"2017","unstructured":"Flanagan DJ, Vincan E, Phesse TJ. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers. Br J Pharmacol. 2017;174:4666\u201383.","journal-title":"Br J Pharmacol"},{"key":"2466_CR49","doi-asserted-by":"publisher","first-page":"e2245836","DOI":"10.1001\/jamanetworkopen.2022.45836","volume":"5","author":"Z-X Liu","year":"2022","unstructured":"Liu Z-X, Zhang X-L, Zhao Q, Chen Y, Sheng H, He C-Y, Sun Y-T, Lai M-Y, Wu M-Q, Zuo Z-X. Whole-exome sequencing among Chinese patients with hereditary diffuse gastric cancer. JAMA Netw Open. 2022;5:e2245836\u20132245836.","journal-title":"JAMA Netw Open"},{"key":"2466_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMra043186","volume":"357","author":"CA Hudis","year":"2007","unstructured":"Hudis CA. Trastuzumab\u2014mechanism of action and use in clinical practice. N Engl J Med. 2007;357:39\u201351.","journal-title":"N Engl J Med"},{"key":"2466_CR51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrc3236","volume":"12","author":"AM Scott","year":"2012","unstructured":"Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nat Rev Cancer. 2012;12:278\u201387.","journal-title":"Nat Rev Cancer"},{"key":"2466_CR52","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.1158\/1078-0432.CCR-14-1071","volume":"20","author":"M Javle","year":"2014","unstructured":"Javle M, Smyth EC, Chau I. Ramucirumab: successfully targeting angiogenesis in gastric cancer. Clin Cancer Res. 2014;20:5875\u201381.","journal-title":"Clin Cancer Res"},{"key":"2466_CR53","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s10555-014-9505-5","volume":"33","author":"JM Warram","year":"2014","unstructured":"Warram JM, De Boer E, Sorace AG, Chung TK, Kim H, Pleijhuis RG, et al. Antibody-based imaging strategies for cancer. Cancer Metastasis Rev. 2014;33:809\u201322.","journal-title":"Cancer Metastasis Rev"},{"key":"2466_CR54","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375:1856\u201367.","journal-title":"N Engl J Med"},{"key":"2466_CR55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.actbio.2024.05.037","volume":"183","author":"Y Takahashi","year":"2024","unstructured":"Takahashi Y, Morimura R, Tsukamoto K, Gomi S, Yamada A, Mizukami M, Naito Y, Irie S, Nagayama S, Shinozaki E. In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues. Acta Biomater. 2024;183:111\u201329.","journal-title":"Acta Biomater"},{"key":"2466_CR56","doi-asserted-by":"publisher","first-page":"2412815","DOI":"10.1002\/adma.202412815","volume":"37","author":"Y Du","year":"2025","unstructured":"Du Y, Wang YR, Bao QY, Xu XX, Xu C, Wang S, Liu Q, Liu F, Zeng YL, Wang YJ. Personalized vascularized tumor Organoid-on\u2010a\u2010Chip for tumor metastasis and therapeutic targeting assessment. Adv Mater. 2025;37:2412815.","journal-title":"Adv Mater"},{"key":"2466_CR57","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1158\/1078-0432.CCR-12-0625","volume":"18","author":"MC Heinrich","year":"2012","unstructured":"Heinrich MC, Griffith D, McKinley A, Patterson J, Presnell A, Ramachandran A, et al. Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors. Clin Cancer Res. 2012;18:4375\u201384.","journal-title":"Clin Cancer Res"},{"key":"2466_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395\u2013406.","journal-title":"J Cell Biol"},{"key":"2466_CR59","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.yexcr.2010.02.045","volume":"316","author":"K Pietras","year":"2010","unstructured":"Pietras K, \u00d6stman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res. 2010;316:1324\u201331.","journal-title":"Exp Cell Res"},{"key":"2466_CR60","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","volume":"164","author":"AK Palucka","year":"2016","unstructured":"Palucka AK, Coussens LM. The basis of oncoimmunology. Cell. 2016;164:1233\u201347.","journal-title":"Cell"},{"key":"2466_CR61","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","volume":"25","author":"F Klemm","year":"2015","unstructured":"Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 2015;25:198\u2013213.","journal-title":"Trends Cell Biol"},{"key":"2466_CR62","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, De Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346\u201354.","journal-title":"Nature"},{"key":"2466_CR63","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell. 2018;174:1586\u201398. e1512.","journal-title":"Cell"},{"key":"2466_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","volume":"15","author":"CM Cattaneo","year":"2020","unstructured":"Cattaneo CM, Dijkstra KK, Fanchi LF, Kelderman S, Kaing S, van Rooij N, van den Brink S, Schumacher TN, Voest EE. Tumor organoid\u2013T-cell coculture systems. Nat Protoc. 2020;15:15\u201339.","journal-title":"Nat Protoc"},{"key":"2466_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6686","volume":"9","author":"L Sun","year":"2023","unstructured":"Sun L, Kang X, Ju H, Wang C, Yang G, Wang R, et al. A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options. Sci Adv. 2023;9:eadg6686.","journal-title":"Sci Adv"},{"key":"2466_CR66","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41416-022-01839-x","volume":"127","author":"G Zhou","year":"2022","unstructured":"Zhou G, Lieshout R, van Tienderen GS, de Ruiter V, van Royen ME, Boor PP, Magr\u00e9 L, Desai J, K\u00f6ten K, Kan YY. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells. Br J Cancer. 2022;127:649\u201360.","journal-title":"Br J Cancer"},{"key":"2466_CR67","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24:523\u201339.","journal-title":"Nat Rev Cancer"},{"key":"2466_CR68","doi-asserted-by":"publisher","first-page":"2203966","DOI":"10.1002\/adfm.202203966","volume":"32","author":"M Dey","year":"2022","unstructured":"Dey M, Kim MH, Dogan M, Nagamine M, Kozhaya L, Celik N, Unutmaz D, Ozbolat IT. Chemotherapeutics and CAR-T cell\u2010based immunotherapeutics screening on a 3D bioprinted vascularized breast tumor model. Adv Funct Mater. 2022;32:2203966.","journal-title":"Adv Funct Mater"},{"key":"2466_CR69","unstructured":"Jenks GF. Optimal data classification for choropleth maps. G F Jenks, U O K D Geography, Optimal Data Classification forChoropleth Maps, University of Kansas, Lawrence, USA 1977 1977."},{"key":"2466_CR70","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1158\/1078-0432.CCR-20-4116","volume":"28","author":"JE Grossman","year":"2022","unstructured":"Grossman JE, Muthuswamy L, Huang L, Akshinthala D, Perea S, Gonzalez RS, et al. Organoid sensitivity correlates with therapeutic response in patients with pancreatic cancer. Clin Cancer Res. 2022;28:708\u201318.","journal-title":"Clin Cancer Res"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02466-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02466-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:07:53Z","timestamp":1760458073000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02466-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2466"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02466-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6762600\/v1","asserted-by":"object"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Ethical approval was granted by the Medical Ethics Committee of Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences (No. I-24PJ1473), and human materials were collected after obtaining informed consent from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"259"}}